Our Latest News


November 11, 2020

Psyomics secures £1.5m funding to transform mental health diagnosis in the UK

Psyomics Ltd, a UK-based healthtech and University of Cambridge spin-out, has closed a £1.5 million funding round from existing and new investors to bring its mental health assessment and diagnosis platform, Censeo, to market in the UK. University spinout specialists Parkwalk led the round, joined by fellow existing investors Jonathan Milner, Martlet, and Cambridge Enterprise. […]

Read more

November 9, 2020

Psyomics appoints Barnaby Perks as Non-executive Director

Psyomics is delighted to announce that the Board has appointed Barnaby Perks as a new non-executive director. Mr Perks will assume his position from April 2018. Mr Perks brings to Psyomics a decade’s worth of experience in commercial strategy as a biotech leader which will be invaluable in helping Psyomics’ new digital tools reach the […]

Read more

Cambridge research aims to improve accuracy of mental health diagnosis

New research into improving the diagnosis of bipolar disorder and depression could help improve the lives of millions of people. Psyomics has received funding from the largest EU Research and Innovation programme, Horizon 2020 in recognition of potential success. This funding will help support the scientific development of an online screening system and research into […]

Read more

October 22, 2020

Psyomics wins prestigious AXA PPP Health Tech & You award

Psyomics has strengthened its position as one of the most exciting new health technology start-ups by winning the Problem/Solution category of the prestigious AXA PPP Health Tech & You Awards, 2016. The awards recognise the most forward-thinking companies in developing innovative technologies to help individuals manage their own health, either by helping them to deal […]

Read more